![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 19623 |
FusionGeneSummary for LEPREL1_TP63 |
![]() |
Fusion gene information | Fusion gene name: LEPREL1_TP63 | Fusion gene ID: 19623 | Hgene | Tgene | Gene symbol | LEPREL1 | TP63 | Gene ID | 55214 | 8626 |
Gene name | prolyl 3-hydroxylase 2 | tumor protein p63 | |
Synonyms | LEPREL1|MCVD|MLAT4 | AIS|B(p51A)|B(p51B)|EEC3|KET|LMS|NBP|OFC8|RHS|SHFM4|TP53CP|TP53L|TP73L|p40|p51|p53CP|p63|p73H|p73L | |
Cytomap | 3q28 | 3q28 | |
Type of gene | protein-coding | protein-coding | |
Description | prolyl 3-hydroxylase 2leprecan-like 1myxoid liposarcoma-associated protein 4procollagen-proline 3-dioxygenase 2prolyl 3-hydroxylase 3 | tumor protein 63amplified in squamous cell carcinomachronic ulcerative stomatitis proteinkeratinocyte transcription factor KETtransformation-related protein 63tumor protein p53-competing protein | |
Modification date | 20180523 | 20180521 | |
UniProtAcc | Q9H3D4 | ||
Ensembl transtripts involved in fusion gene | ENST00000319332, ENST00000427335, | ENST00000264731, ENST00000382063, ENST00000418709, ENST00000320472, ENST00000392460, ENST00000440651, ENST00000354600, ENST00000437221, ENST00000392463, ENST00000392461, ENST00000456148, ENST00000449992, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 6 X 5 X 4=120 |
# samples | 1 | 6 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LEPREL1 [Title/Abstract] AND TP63 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. Transcription factor involved fusion gene, inframe and retained DNA-binding domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LEPREL1 | GO:0008285 | negative regulation of cell proliferation | 19436308 |
Hgene | LEPREL1 | GO:0019511 | peptidyl-proline hydroxylation | 18487197 |
Hgene | LEPREL1 | GO:0032963 | collagen metabolic process | 18487197 |
Tgene | TP63 | GO:0045747 | positive regulation of Notch signaling pathway | 11641404 |
Tgene | TP63 | GO:0045892 | negative regulation of transcription, DNA-templated | 12446784 |
Tgene | TP63 | GO:0045893 | positive regulation of transcription, DNA-templated | 12446784|16343436 |
Tgene | TP63 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 22521434 |
Tgene | TP63 | GO:2000271 | positive regulation of fibroblast apoptotic process | 9774969 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-CS-4942-01A | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000319332 | ENST00000264731 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000382063 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000418709 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000320472 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000392460 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000440651 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000354600 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000437221 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000392463 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000392461 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000456148 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
5CDS-intron | ENST00000319332 | ENST00000449992 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-3CDS | ENST00000427335 | ENST00000264731 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000382063 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000418709 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000320472 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000392460 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000440651 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000354600 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000437221 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000392463 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000392461 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000456148 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
intron-intron | ENST00000427335 | ENST00000449992 | LEPREL1 | chr3 | 189838041 | - | TP63 | chr3 | 189526061 | + |
Top |
FusionProtFeatures for LEPREL1_TP63 |
![]() |
Hgene | Tgene |
LEPREL1 | TP63 |
Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 93_99 | 160 | 709 | Compositional bias | Note=Poly-Pro |
Hgene | LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 44_77 | 160 | 709 | Repeat | Note=TPR 1 |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 437_444 | 108 | 681 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 437_444 | 108 | 511 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 437_444 | 14 | 587 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 437_444 | -30 | 596 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 437_444 | 108 | 556 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 437_444 | 14 | 417 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 437_444 | 14 | 462 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 437_444 | 108 | 488 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 437_444 | 14 | 394 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 437_444 | 108 | 677 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 437_444 | 0 | 502 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 437_444 | 14 | 583 | Compositional bias | Note=Poly-Gln |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 170_362 | 108 | 681 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 170_362 | 108 | 511 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 170_362 | 14 | 587 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 170_362 | -30 | 596 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 170_362 | 108 | 556 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 170_362 | 14 | 417 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 170_362 | 14 | 462 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 170_362 | 108 | 488 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 170_362 | 14 | 394 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 170_362 | 108 | 677 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 170_362 | 0 | 502 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 170_362 | 14 | 583 | DNA binding | . |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 541_607 | 108 | 681 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 541_607 | 108 | 511 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 541_607 | 14 | 587 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 541_607 | -30 | 596 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 541_607 | 108 | 556 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 541_607 | 14 | 417 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 541_607 | 14 | 462 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 541_607 | 108 | 488 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 541_607 | 14 | 394 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 541_607 | 108 | 677 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 541_607 | 0 | 502 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 541_607 | 14 | 583 | Domain | Note=SAM |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 394_443 | 108 | 681 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 610_680 | 108 | 681 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 394_443 | 108 | 511 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 610_680 | 108 | 511 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 394_443 | 14 | 587 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 610_680 | 14 | 587 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 1_107 | -30 | 596 | Region | Note=Transcription activation |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 394_443 | -30 | 596 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 610_680 | -30 | 596 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 394_443 | 108 | 556 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 610_680 | 108 | 556 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 394_443 | 14 | 417 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 610_680 | 14 | 417 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 394_443 | 14 | 462 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 610_680 | 14 | 462 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 394_443 | 108 | 488 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 610_680 | 108 | 488 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 394_443 | 14 | 394 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 610_680 | 14 | 394 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 394_443 | 108 | 677 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 610_680 | 108 | 677 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 1_107 | 0 | 502 | Region | Note=Transcription activation |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 394_443 | 0 | 502 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 610_680 | 0 | 502 | Region | Note=Transactivation inhibition |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 394_443 | 14 | 583 | Region | Note=Oligomerization |
Tgene | >TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 610_680 | 14 | 583 | Region | Note=Transactivation inhibition |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 557_671 | 160 | 709 | Domain | Fe2OG dioxygenase |
Hgene | >LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 705_708 | 160 | 709 | Motif | Prevents secretion from ER |
Hgene | >LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 148_181 | 160 | 709 | Repeat | Note=TPR 2 |
Hgene | >LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 210_243 | 160 | 709 | Repeat | Note=TPR 3 |
Hgene | >LEPREL1 | chr3:189838041 | chr3:189526061 | ENST00000319332 | - | 1 | 15 | 306_339 | 160 | 709 | Repeat | Note=TPR 4 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 1_107 | 108 | 681 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 1_107 | 108 | 511 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 1_107 | 14 | 587 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 1_107 | 108 | 556 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 1_107 | 14 | 417 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 1_107 | 14 | 462 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 1_107 | 108 | 488 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 1_107 | 14 | 394 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 1_107 | 108 | 677 | Region | Note=Transcription activation |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 1_107 | 14 | 583 | Region | Note=Transcription activation |
Top |
FusionGeneSequence for LEPREL1_TP63 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_LEPREL1_ENST00000319332_chr3_189838041_-_TP63_ENST00000264731_chr3_189526061_+_733aa MRERIWAPPLLLLLPLLLPPPLWGGPPDSPRRELELEPGPLQPFDLLYASGAAAYYSGDYERAVRDLEAALRSHRRLREIRTRCARHCAA RHPLPPPPPGEGPGAELPLFRSLLGRARCYRSCETQRLGGPASRHRVSEDVRSDFQRRVPYNYLQRAYIKPQYTNLGLLNSMDQQIQNGS SSTSPYNTDHAQNSVTAPSPYAQPSSTFDALSPSPAIPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTP PPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMC NSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQQVSDSTKNGDGTKRPFRQNTHGIQMTSIKKRRSPDD ELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQQHQHLLQKQTSIQSPSSYGNSSPPLNKMNSMNKLPSVSQLINPQQRN ALTPTTIPDGMGANIPMMGTHMPMAGDMNGLSPTQALPPPLSMPSTSHCTPPPPYPTDCSIVSFLARLGCSSCLDYFTTQGLTTIYQIEH YSMDDLASLKIPEQFRHAIWKGILDHRQLHEFSSPSHLLRTPSSASTVSVGSSETRGERVIDAVRFTLRQTISFPPRDEWNDFNFDMDAR |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_LEPREL1_ENST00000319332_chr3_189838041_-_TP63_ENST00000264731_chr3_189526061_+_2199nt ATGCGGGAGCGCATCTGGGCGCCGCCGCTGCTGCTGCTGCTGCCGCTGCTACTGCCGCCGCCACTGTGGGGCGGCCCCCCGGACAGCCCA CGCCGGGAGCTGGAGCTGGAGCCCGGGCCTCTGCAGCCCTTCGACCTGCTCTACGCCAGCGGCGCGGCCGCCTACTACAGCGGAGACTAC GAGCGAGCGGTGCGCGACTTGGAAGCGGCGCTGCGCAGCCACCGGCGCCTGCGGGAAATCCGCACGCGCTGTGCCCGCCACTGCGCGGCG CGCCACCCGCTCCCGCCCCCGCCCCCCGGCGAGGGCCCCGGCGCTGAGCTGCCCCTTTTCCGCTCCTTGTTGGGGCGGGCGCGCTGTTAT CGCAGCTGTGAGACCCAGCGCCTCGGGGGCCCCGCATCCCGCCACCGCGTCAGCGAGGATGTGCGCAGCGACTTCCAGCGCAGAGTGCCC TACAACTACCTGCAGCGGGCCTACATCAAGCCACAGTACACGAACCTGGGGCTCCTGAACAGCATGGACCAGCAGATTCAGAACGGCTCC TCGTCCACCAGTCCCTATAACACAGACCACGCGCAGAACAGCGTCACGGCGCCCTCGCCCTACGCACAGCCCAGCTCCACCTTCGATGCT CTCTCTCCATCACCCGCCATCCCCTCCAACACCGACTACCCAGGCCCGCACAGTTTCGACGTGTCCTTCCAGCAGTCGAGCACCGCCAAG TCGGCCACCTGGACGTATTCCACTGAACTGAAGAAACTCTACTGCCAAATTGCAAAGACATGCCCCATCCAGATCAAGGTGATGACCCCA CCTCCTCAGGGAGCTGTTATCCGCGCCATGCCTGTCTACAAAAAAGCTGAGCACGTCACGGAGGTGGTGAAGCGGTGCCCCAACCATGAG CTGAGCCGTGAATTCAACGAGGGACAGATTGCCCCTCCTAGTCATTTGATTCGAGTAGAGGGGAACAGCCATGCCCAGTATGTAGAAGAT CCCATCACAGGAAGACAGAGTGTGCTGGTACCTTATGAGCCACCCCAGGTTGGCACTGAATTCACGACAGTCTTGTACAATTTCATGTGT AACAGCAGTTGTGTTGGAGGGATGAACCGCCGTCCAATTTTAATCATTGTTACTCTGGAAACCAGAGATGGGCAAGTCCTGGGCCGACGC TGCTTTGAGGCCCGGATCTGTGCTTGCCCAGGAAGAGACAGGAAGGCGGATGAAGATAGCATCAGAAAGCAGCAAGTTTCGGACAGTACA AAGAACGGTGATGGTACGAAGCGCCCGTTTCGTCAGAACACACATGGTATCCAGATGACATCCATCAAGAAACGAAGATCCCCAGATGAT GAACTGTTATACTTACCAGTGAGGGGCCGTGAGACTTATGAAATGCTGTTGAAGATCAAAGAGTCCCTGGAACTCATGCAGTACCTTCCT CAGCACACAATTGAAACGTACAGGCAACAGCAACAGCAGCAGCACCAGCACTTACTTCAGAAACAGACCTCAATACAGTCTCCATCTTCA TATGGTAACAGCTCCCCACCTCTGAACAAAATGAACAGCATGAACAAGCTGCCTTCTGTGAGCCAGCTTATCAACCCTCAGCAGCGCAAC GCCCTCACTCCTACAACCATTCCTGATGGCATGGGAGCCAACATTCCCATGATGGGCACCCACATGCCAATGGCTGGAGACATGAATGGA CTCAGCCCCACCCAGGCACTCCCTCCCCCACTCTCCATGCCATCCACCTCCCACTGCACACCCCCACCTCCGTATCCCACAGATTGCAGC ATTGTCAGTTTCTTAGCGAGGTTGGGCTGTTCATCATGTCTGGACTATTTCACGACCCAGGGGCTGACCACCATCTATCAGATTGAGCAT TACTCCATGGATGATCTGGCAAGTCTGAAAATCCCTGAGCAATTTCGACATGCGATCTGGAAGGGCATCCTGGACCACCGGCAGCTCCAC GAATTCTCCTCCCCTTCTCATCTCCTGCGGACCCCAAGCAGTGCCTCTACAGTCAGTGTGGGCTCCAGTGAGACCCGGGGTGAGCGTGTT ATTGATGCTGTGCGATTCACCCTCCGCCAGACCATCTCTTTCCCACCCCGAGATGAGTGGAATGACTTCAACTTTGACATGGATGCTCGC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_LEPREL1_ENST00000319332_chr3_189838041_-_TP63_ENST00000264731_chr3_189526061_+_5174nt CCTTTAAGAGCGGCTGGCCAGGCACGGCCTCCGCCTCTCAGTACGCGGAGCGCCGGCGGTCACCTGGGGCTCGCGGAGCGGCCAGATCGC GGCGGAGTCGGCGCGCTTCCCCGAGGGAAGGTGGGAGAGGGGACCCGGACGCGAGGTGCCCCGAAGCCCTCTCGAGCGTAACCGTCCCGC GCCTCTCTGAGGCGGAGGATGCGGGAGCGCATCTGGGCGCCGCCGCTGCTGCTGCTGCTGCCGCTGCTACTGCCGCCGCCACTGTGGGGC GGCCCCCCGGACAGCCCACGCCGGGAGCTGGAGCTGGAGCCCGGGCCTCTGCAGCCCTTCGACCTGCTCTACGCCAGCGGCGCGGCCGCC TACTACAGCGGAGACTACGAGCGAGCGGTGCGCGACTTGGAAGCGGCGCTGCGCAGCCACCGGCGCCTGCGGGAAATCCGCACGCGCTGT GCCCGCCACTGCGCGGCGCGCCACCCGCTCCCGCCCCCGCCCCCCGGCGAGGGCCCCGGCGCTGAGCTGCCCCTTTTCCGCTCCTTGTTG GGGCGGGCGCGCTGTTATCGCAGCTGTGAGACCCAGCGCCTCGGGGGCCCCGCATCCCGCCACCGCGTCAGCGAGGATGTGCGCAGCGAC TTCCAGCGCAGAGTGCCCTACAACTACCTGCAGCGGGCCTACATCAAGCCACAGTACACGAACCTGGGGCTCCTGAACAGCATGGACCAG CAGATTCAGAACGGCTCCTCGTCCACCAGTCCCTATAACACAGACCACGCGCAGAACAGCGTCACGGCGCCCTCGCCCTACGCACAGCCC AGCTCCACCTTCGATGCTCTCTCTCCATCACCCGCCATCCCCTCCAACACCGACTACCCAGGCCCGCACAGTTTCGACGTGTCCTTCCAG CAGTCGAGCACCGCCAAGTCGGCCACCTGGACGTATTCCACTGAACTGAAGAAACTCTACTGCCAAATTGCAAAGACATGCCCCATCCAG ATCAAGGTGATGACCCCACCTCCTCAGGGAGCTGTTATCCGCGCCATGCCTGTCTACAAAAAAGCTGAGCACGTCACGGAGGTGGTGAAG CGGTGCCCCAACCATGAGCTGAGCCGTGAATTCAACGAGGGACAGATTGCCCCTCCTAGTCATTTGATTCGAGTAGAGGGGAACAGCCAT GCCCAGTATGTAGAAGATCCCATCACAGGAAGACAGAGTGTGCTGGTACCTTATGAGCCACCCCAGGTTGGCACTGAATTCACGACAGTC TTGTACAATTTCATGTGTAACAGCAGTTGTGTTGGAGGGATGAACCGCCGTCCAATTTTAATCATTGTTACTCTGGAAACCAGAGATGGG CAAGTCCTGGGCCGACGCTGCTTTGAGGCCCGGATCTGTGCTTGCCCAGGAAGAGACAGGAAGGCGGATGAAGATAGCATCAGAAAGCAG CAAGTTTCGGACAGTACAAAGAACGGTGATGGTACGAAGCGCCCGTTTCGTCAGAACACACATGGTATCCAGATGACATCCATCAAGAAA CGAAGATCCCCAGATGATGAACTGTTATACTTACCAGTGAGGGGCCGTGAGACTTATGAAATGCTGTTGAAGATCAAAGAGTCCCTGGAA CTCATGCAGTACCTTCCTCAGCACACAATTGAAACGTACAGGCAACAGCAACAGCAGCAGCACCAGCACTTACTTCAGAAACAGACCTCA ATACAGTCTCCATCTTCATATGGTAACAGCTCCCCACCTCTGAACAAAATGAACAGCATGAACAAGCTGCCTTCTGTGAGCCAGCTTATC AACCCTCAGCAGCGCAACGCCCTCACTCCTACAACCATTCCTGATGGCATGGGAGCCAACATTCCCATGATGGGCACCCACATGCCAATG GCTGGAGACATGAATGGACTCAGCCCCACCCAGGCACTCCCTCCCCCACTCTCCATGCCATCCACCTCCCACTGCACACCCCCACCTCCG TATCCCACAGATTGCAGCATTGTCAGTTTCTTAGCGAGGTTGGGCTGTTCATCATGTCTGGACTATTTCACGACCCAGGGGCTGACCACC ATCTATCAGATTGAGCATTACTCCATGGATGATCTGGCAAGTCTGAAAATCCCTGAGCAATTTCGACATGCGATCTGGAAGGGCATCCTG GACCACCGGCAGCTCCACGAATTCTCCTCCCCTTCTCATCTCCTGCGGACCCCAAGCAGTGCCTCTACAGTCAGTGTGGGCTCCAGTGAG ACCCGGGGTGAGCGTGTTATTGATGCTGTGCGATTCACCCTCCGCCAGACCATCTCTTTCCCACCCCGAGATGAGTGGAATGACTTCAAC TTTGACATGGATGCTCGCCGCAATAAGCAACAGCGCATCAAAGAGGAGGGGGAGTGAGCCTCACCATGTGAGCTCTTCCTATCCCTCTCC TAACTGCCAGCCCCCTAAAAGCACTCCTGCTTAATCTTCAAAGCCTTCTCCCTAGCTCCTCCCCTTCCTCTTGTCTGATTTCTTAGGGGA AGGAGAAGTAAGAGGCTACCTCTTACCTAACATCTGACCTGGCATCTAATTCTGATTCTGGCTTTAAGCCTTCAAAACTATAGCTTGCAG AACTGTAGCTGCCATGGCTAGGTAGAAGTGAGCAAAAAAGAGTTGGGTGTCTCCTTAAGCTGCAGAGATTTCTCATTGACTTTTATAAAG CATGTTCACCCTTATAGTCTAAGACTATATATATAAATGTATAAATATACAGTATAGATTTTTGGGTGGGGGGCATTGAGTATTGTTTAA AATGTAATTTAAATGAAAGAAAATTGAGTTGCACTTATTGACCATTTTTTAATTTACTTGTTTTGGATGGCTTGTCTATACTCCTTCCCT TAAGGGGTATCATGTATGGTGATAGGTATCTAGAGCTTAATGCTACATGTGAGTGACGATGATGTACAGATTCTTTCAGTTCTTTGGATT CTAAATACATGCCACATCAAACCTTTGAGTAGATCCATTTCCATTGCTTATTATGTAGGTAAGACTGTAGATATGTATTCTTTTCTCAGT GTTGGTATATTTTATATTACTGACATTTCTTCTAGTGATGATGGTTCACGTTGGGGTGATTTAATCCAGTTATAAGAAGAAGTTCATGTC CAAACGTCCTCTTTAGTTTTTGGTTGGGAATGAGGAAAATTCTTAAAAGGCCCATAGCAGCCAGTTCAAAAACACCCGACGTCATGTATT TGAGCATATCAGTAACCCCCTTAAATTTAATACCAGATACCTTATCTTACAATATTGATTGGGAAAACATTTGCTGCCATTACAGAGGTA TTAAAACTAAATTTCACTACTAGATTGACTAACTCAAATACACATTTGCTACTGTTGTAAGAATTCTGATTGATTTGATTGGGATGAATG CCATCTATCTAGTTCTAACAGTGAAGTTTTACTGTCTATTAATATTCAGGGTAAATAGGAATCATTCAGAAATGTTGAGTCTGTACTAAA CAGTAAGATATCTCAATGAACCATAAATTCAACTTTGTAAAAATCTTTTGAAGCATAGATAATATTGTTTGGTAAATGTTTCTTTTGTTT GGTAAATGTTTCTTTTAAAGACCCTCCTATTCTATAAAACTCTGCATGTAGAGGCTTGTTTACCTTTCTCTCTCTAAGGTTTACAATAGG AGTGGTGATTTGAAAAATATAAAATTATGAGATTGGTTTTCCTGTGGCATAAATTGCATCACTGTATCATTTTCTTTTTTAACCGGTAAG AGTTTCAGTTTGTTGGAAAGTAACTGTGAGAACCCAGTTTCCCGTCCATCTCCCTTAGGGACTACCCATAGACATGAAAGGTCCCCACAG AGCAAGAGATAAGTCTTTCATGGCTGCTGTTGCTTAAACCACTTAAACGAAGAGTTCCCTTGAAACTTTGGGAAAACATGTTAATGACAA TATTCCAGATCTTTCAGAAATATAACACATTTTTTTGCATGCATGCAAATGAGCTCTGAAATCTTCCCATGCATTCTGGTCAAGGGCTGT CATTGCACATAAGCTTCCATTTTAATTTTAAAGTGCAAAAGGGCCAGCGTGGCTCTAAAAGGTAATGTGTGGATTGCCTCTGAAAAGTGT GTATATATTTTGTGTGAAATTGCATACTTTGTATTTTGATTATTTTTTTTTTCTTCTTGGGATAGTGGGATTTCCAGAACCACACTTGAA ACCTTTTTTTATCGTTTTTGTATTTTCATGAAAATACCATTTAGTAAGAATACCACATCAAATAAGAAATAATGCTACAATTTTAAGAGG GGAGGGAAGGGAAAGTTTTTTTTTATTATTTTTTTAAAATTTTGTATGTTAAAGAGAATGAGTCCTTGATTTCAAAGTTTTGTTGTACTT AAATGGTAATAAGCACTGTAAACTTCTGCAACAAGCATGCAGCTTTGCAAACCCATTAAGGGGAAGAATGAAAGCTGTTCCTTGGTCCTA GTAAGAAGACAAACTGCTTCCCTTACTTTGCTGAGGGTTTGAATAAACCTAGGACTTCCGAGCTATGTCAGTACTATTCAGGTAACACTA GGGCCTTGGAAATTCCTGTACTGTGTCTCATGGATTTGGCACTAGCCAAAGCGAGGCACCCTTACTGGCTTACCTCCTCATGGCAGCCTA CTCTCCTTGAGTGTATGAGTAGCCAGGGTAAGGGGTAAAAGGATAGTAAGCATAGAAACCACTAGAAAGTGGGCTTAATGGAGTTCTTGT GGCCTCAGCTCAATGCAGTTAGCTGAAGAATTGAAAAGTTTTTGTTTGGAGACGTTTATAAACAGAAATGGAAAGCAGAGTTTTCATTAA ATCCTTTTACCTTTTTTTTTTCTTGGTAATCCCCTAAAATAACAGTATGTGGGATATTGAATGTTAAAGGGATATTTTTTTCTATTATTT TTATAATTGTACAAAATTAAGCAAATGTTAAAAGTTTTATATGCTTTATTAATGTTTTCAAAAGGTATTATACATGTGATACATTTTTTA AGCTTCAGTTGCTTGTCTTCTGGTACTTTCTGTTATGGGCTTTTGGGGAGCCAGAAGCCAATCTACAATCTCTTTTTGTTTGCCAGGACA |
Top |
FusionGenePPI for LEPREL1_TP63 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
LEPREL1 | TP63 | HNRNPAB, GNB2L1, SCAF4, YAP1, HIPK2, BTRC, ADH5, AGBL2, ASPM, BRD8, NPRL3, TRAPPC11, CDT1, DAB2IP, DDX23, DNAJB6, DPH1, AGO1, AGO2, GAS8, IGF2BP1, LOC613037, JPH1, MTHFSD, MYL9, N4BP2, PIWIL1, RNF38, SMARCD2, TRMT11, EMX1, ITCH, MDM2, MDM4, WWP1, RELA, BRCA1, CHUK, IKBKB, FBXW7, CDKN2A, CDKN1A, TP53, RBL2, SFN, UBE2I, SUMO1, UBE4B, DAXX, PML, RCHY1, WWOX, FAS, CAD, FLNC, DHX9, SEC24C, VCP, SACS, PSMD2, HNRNPR, GOLGA4, HSPA5, FUS, A2M, SYNCRIP, ZNF676, TP63, CPSF6, PLS3, KRT5, CARM1, HNRNPL, CCT8, NONO, HNRNPK, KRT6C, TUBA1C, ATP5A1, RPL3, EEF1A1, RPSA, ZBTB4, HNRNPCL1, HNRNPA3, MAP1A, RPLP0, HIST1H1D, UACA, SNRPA, UPF2, CENPE, SAFB, S1PR5, RPL24, RPL13A, RPL12, MYLPF, HSP90AB1, ETV4, CEBPB, NFYA, NFKB1, STK11, NIPSNAP3A, ORM1, CCNC, ITIH4, BAG6, GCGR, HP, HPX, COPS6, SLC35A3, PINX1, SMAD3, RNF144B, EP300, KAT2B, CEP83, CHEK2, TP73, SH3KBP1, RPH3A, FOXK1, FOXK2, PEX14, ATF3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000264731 | + | 2 | 14 | 352_388 | 108 | 681 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000320472 | + | 2 | 12 | 352_388 | 108 | 511 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000354600 | + | 0 | 12 | 352_388 | 14 | 587 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000382063 | + | 0 | 13 | 352_388 | -30 | 596 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392460 | + | 2 | 13 | 352_388 | 108 | 556 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392461 | + | 0 | 10 | 352_388 | 14 | 417 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000392463 | + | 0 | 11 | 352_388 | 14 | 462 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000418709 | + | 2 | 11 | 352_388 | 108 | 488 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000437221 | + | 0 | 9 | 352_388 | 14 | 394 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000440651 | + | 2 | 14 | 352_388 | 108 | 677 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000449992 | + | 0 | 11 | 352_388 | 0 | 502 | HIPK2 |
Tgene | TP63 | chr3:189838041 | chr3:189526061 | ENST00000456148 | + | 0 | 12 | 352_388 | 14 | 583 | HIPK2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LEPREL1_TP63 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LEPREL1_TP63 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | TP63 | C1785148 | RAPP-HODGKIN SYNDROME | 6 | CTD_human;ORPHANET;UNIPROT |
Tgene | TP63 | C1858562 | ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3 | 5 | CTD_human;UNIPROT |
Tgene | TP63 | C0406709 | Hay-Wells syndrome | 3 | CTD_human;UNIPROT |
Tgene | TP63 | C0024121 | Lung Neoplasms | 2 | CTD_human |
Tgene | TP63 | C1854442 | SPLIT-HAND/FOOT MALFORMATION 4 | 2 | CTD_human;UNIPROT |
Tgene | TP63 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Tgene | TP63 | C0006145 | Breast Diseases | 1 | CTD_human |
Tgene | TP63 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Tgene | TP63 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Tgene | TP63 | C0008924 | Cleft Lip | 1 | CTD_human;HPO;ORPHANET |
Tgene | TP63 | C0008925 | Cleft Palate | 1 | CTD_human;HPO |
Tgene | TP63 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Tgene | TP63 | C0016508 | Congenital Foot Deformity | 1 | CTD_human |
Tgene | TP63 | C0018566 | Congenital Hand Deformities | 1 | CTD_human |
Tgene | TP63 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | TP63 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Tgene | TP63 | C0037268 | Skin Abnormalities | 1 | CTD_human |
Tgene | TP63 | C0038987 | Sweat Gland Neoplasms | 1 | CTD_human |
Tgene | TP63 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | TP63 | C0206720 | Squamous Cell Neoplasms | 1 | CTD_human |
Tgene | TP63 | C0206762 | Limb Deformities, Congenital | 1 | CTD_human |
Tgene | TP63 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Tgene | TP63 | C0406704 | Rudiger syndrome 1 | 1 | CTD_human;ORPHANET |
Tgene | TP63 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Tgene | TP63 | C1720887 | Female Urogenital Diseases | 1 | CTD_human |
Tgene | TP63 | C1863204 | ADULT SYNDROME | 1 | CTD_human;ORPHANET;UNIPROT |
Tgene | TP63 | C1863753 | LIMB-MAMMARY SYNDROME | 1 | CTD_human;ORPHANET |